Loading...
XJPX4892
Market cap22mUSD
Jan 07, Last price  
446.00JPY
1D
-0.45%
1Q
-22.97%
IPO
-79.86%
Name

Cyfuse Biomedical KK

Chart & Performance

D1W1MN
XJPX:4892 chart
P/E
P/S
56.98
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
61m
-83.68%
137,484,000708,245,000374,477,00061,112,000
Net income
-589m
L+24.32%
-329,501,000142,905,000-473,962,000-589,211,000
CFO
-562m
L+39.32%
-294,001,000161,537,000-403,596,000-562,296,000

Profile

Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.
IPO date
Dec 01, 2022
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFY
2023‑122022‑122021‑122020‑12
Income
Revenues
61,112
-83.68%
374,477
-47.13%
Cost of revenue
749,368
781,982
Unusual Expense (Income)
NOPBT
(688,256)
(407,505)
NOPBT Margin
Operating Taxes
3,024
2,009
Tax Rate
NOPAT
(691,280)
(409,514)
Net income
(589,211)
24.32%
(473,962)
-431.66%
Dividends
Dividend yield
Proceeds from repurchase of equity
22,880
2,328,247
BB yield
-0.38%
-67.09%
Debt
Debt current
549,000
545,144
Long-term debt
345,000
363,000
Deferred revenue
Other long-term liabilities
Net debt
(2,979,783)
(3,584,163)
Cash flow
Cash from operating activities
(562,296)
(403,596)
CAPEX
(19,474)
(228,276)
Cash from investing activities
(19,474)
(430,674)
Cash from financing activities
18,236
2,658,538
FCF
(648,592)
(571,211)
Balance
Cash
3,873,773
4,437,307
Long term investments
10
55,000
Excess cash
3,870,727
4,473,583
Stockholders' equity
(702,605)
(124,131)
Invested Capital
4,819,075
4,772,946
ROIC
ROCE
EV
Common stock shares outstanding
7,812
2,668
Price
762.00
-41.43%
1,301.00
 
Market cap
5,952,919
71.53%
3,470,566
 
EV
2,973,136
(113,597)
EBITDA
(650,134)
(353,220)
EV/EBITDA
0.32
Interest
9,774
27,934
Interest/NOPBT